Matthew W. VanBrocklin, Ph.D.

Languages spoken: English

Academic Information

Departments: Surgery - Associate Professor, Oncological Sciences - Adjunct Assistant Professor

Divisions: General Surgery

Academic Office Information

Matthew.VanBrocklin@hci.utah.edu

Labs

Research Interests

  • Molecular Targets
  • Melanoma
  • Carcinoma, Non-Small-Cell Lung
Matthew VanBrocklin, PhD, is an assistant professor in the Department of Surgery at the University of Utah Hospital, an investigator at the Huntsman Cancer Institute (HCI), and a member of the Cell Response and Regulation program.

At HCI, VanBrocklin researches novel therapeutic targets and signal transduction pathways (networks inside a cell that transmit outside signals to influence cellular responses) that are important for increasing survival in melanoma, non-small cell lung cancer (NSCLC), and brain tumors. He also aims to develop novel small peptide-based agents directed at therapeutic targets that are currently considered "undruggable".

Before joining HCI, VanBrocklin was a researcher at the Nevada Cancer Institute, where he completed a postdoctoral fellowship, established his own lab, and became a member of the Drug Development Division. He received a PhD in biomedical science from Western Michigan University in Kalamazoo, Michigan.

Education History

Postdoctoral Fellowship Nevada Cancer Institute
 Postdoctoral Fellow
Doctoral Training Western Michigan University
Biomedical Science 		Ph.D.
Graduate Training Mayo Graduate School
Immunology 		M.S.
Undergraduate Western Michigan University
Biomedical Science/Chemistry 		B.S.
Other Training Bay de Noc Community College